Home - Product - Recombinant Vaccine for Infectious Laryngotracheitis and Fowlpox, Live

Recombinant Vaccine for Infectious Laryngotracheitis and Fowlpox, Live

Generic name of product

Recombinant Vaccine for Infectious Laryngotracheitis and Fowlpox, Live

Main Composition and Content

The vaccine contains recombinant fowlpox virus expressing gB gene of infectious laryngotracheitis virus. The content of the virus is more than 104.0 PFU/dose.

Description

 Light yellow loose mass, easy to detach from the vial wall, dissolves rapidly into pink liquid after addition of diluent.

Functions and Uses

It is used to prevent infectious laryngotracheitis and fowlpox of chickens. The duration of immunity is 5 months.

Usage and Dosage

Dilute with normal saline according to the label dose. Subcutaneously puncture chicks over 21 days of age in the underside of the wings avoiding blood vessels. 3-4 days after inoculation, slight redness, swelling, and occasional scab, may develop at the puncture site. And vaccinated chicks. return to normal after 14 days.

Adverse Reactions

Generally, no visible adverse reactions occur

Precautions

Specifications

(1)1000dose/bottle, 500bottles/carton  (2)2000dose/bottle, 500bottles/carton

Storage and Period of Validity

2-8℃ preservation, valid for 24 months.

Only under the guidance of the veterinary use

Features

1.A single vaccination provides simultaneous prevention of both ILT and FP

2.Significantly reducing vaccination costs and alleviating the burden of disease prevention work.

3.Gene-Engineered Vaccine (rFPV-ILTVgB) – Non-virulent, capable of eliminating field viruses from the environment with long-term use, and absolutely safe.

4.Dissolves instantly in water, featuring a novel heat-resistant stabilizer

滚动至顶部

Become Wollvac Partner

You will usually receive a response within 2 minutes, and at the latest within 24 hours!